Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
1 - 100 out of 256Page size: 100
  1. 2024
  2. Published

    Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

    Fernández, Ó., Sørensen, Per Soelberg, Comi, G., Vermersch, P., Hartung, H. P., Leocani, L., Berger, T., Van Wijmeersch, B. & Oreja-Guevara, C., 2024, In: Frontiers in Immunology. 15, 24 p., 1379538.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Accepted/In press

    Torben Fog – A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research

    Sørensen, Per Soelberg, Bramow, S., Magyari, M., Werdelin, L., Koch-Henriksen, N., Vermersch, P. & Sellebjerg, Finn Thorup, 2024, (Accepted/In press) In: Multiple Sclerosis Journal. 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2023
  5. Published

    An update on combination therapies for multiple sclerosis: where are we now?

    Sørensen, Per Soelberg, Magyari, Melinda & Sellebjerg, Finn Thorup, 2023, In: Expert Review of Neurotherapeutics. 23, 12, p. 1173-1187 15 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience

    Jespersen, F., Petersen, S. L., Andersen, P., Sellebjerg, Finn Thorup, Magyari, M., Sørensen, Per Soelberg & Blinkenberg, M., 2023, In: Multiple Sclerosis and Related Disorders. 76, 7 p., 104829.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis

    the RADAR-CNS Consortium, T. R. C., 2023, In: Frontiers in Physiology. 14, 1145818.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network

    Signori, A., Lorscheider, J., Vukusic, S., Trojano, M., Iaffaldano, P., Hillert, J., Hyde, R., Pellegrini, F., Magyari, M., Koch-Henriksen, N., Sørensen, P. S., Spelman, T., Van Der Walt, A., Horakova, D., Havrdova, E., Girard, M., Eichau, S., Grand'maison, F., Gerlach, O., Terzi, M. & 18 others, Ozakbas, S., Skibina, O., Van Pesch, V., Sa, M. J., Prevost, J., Alroughani, R., McCombe, P. A., Gouider, R., Mrabet, S., Castillo-Trivino, T., Zhu, C., De Gans, K., Sánchez-Menoyo, J. L., Yamout, B., Khoury, S., Sormani, M. P., Kalincik, T. & Butzkueven, H., 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 1, p. 23-30 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Natalizumab treatment of multiple sclerosis — a Danish nationwide study with 13 years of follow-up

    Buron, M. D., Christensen, J. R., Pontieri, L., Joensen, H., Kant, M., Rasmussen, P. V., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Bech, D. & Magyari, M., 2023, In: Multiple Sclerosis and Related Disorders. 74, 9 p., 104713.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis

    Ammitzbøll, C., Dyrby, T. B., Börnsen, L., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Lundell, H., Jensen, P. E. H., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2023, In: Multiple Sclerosis and Related Disorders. 77, 8 p., 104854.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study

    Sørensen, Per Soelberg, Pontieri, L., Joensen, H., Heick, A., Rasmussen, P. V., Schäfer, J., Ratzer, R., Pihl, C. E., Sellebjerg, Finn Thorup & Magyari, M., 2023, In: Multiple Sclerosis and Related Disorders. 70, 9 p., 104491.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    The gut microbiota in multiple sclerosis varies with disease activity

    Thirion, F., Sellebjerg, Finn Thorup, Fan, Yong, Lyu, Liwei, Hansen, T. H., Pons, N., Levenez, F., Quinquis, B., Stankevic, Evelina, Søndergaard, H. B., Dantoft, T. M., Poulsen, C. S., Forslund, S. K., drb459, drb459, Hansen, Torben, Brix, S., Oturai, A., Sørensen, Per Soelberg, Ehrlich, S. D. & Pedersen, Oluf Borbye, 2023, In: Genome Medicine. 15, 17 p., 1.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis

    Gustavsen, S., Olsson, A., Oturai, A. B., Linnet, Kristian, Thomsen, Ragnar, Rasmussen, Brian Schou, Jørgensen, Christian Falck, Langkilde, Annika Reynberg, Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Søndergaard, H. B., 2023, In: European Journal of Neurology. 30, 10, p. 3212-3220

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. 2022
  15. Published

    Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder

    Liu, S., Han, J., Puyal, E. L., Kontaxis, S., Sun, S., Locatelli, P., Dineley, J., Pokorny, F. B., Dalla Costa, G., Leocani, L., Guerrero, A. I., Nos, C., Zabalza, A., Sorensen, P. S., Buron, M., Magyari, M., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C. & 10 others, Folarin, A. A., Dobson, R. J. B., Bailon, R., Vairavan, S., Cummins, N., Narayan, V. A., Hotopf, M., Comi, G., Schuller, B. & RADAR-CNS Consortium, R. C., Mar 2022, In: Pattern Recognition. 123, 10 p., 108403.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis

    Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 6, p. 569-589 21 p.

    Research output: Contribution to journal › Review › Research › peer-review

  17. Published

    Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

    Siddi, S., Giné-Vázquez, I., Bailon, R., Matcham, F., Lamers, F., Kontaxis, S., Laporta, E., Garcia, E., Arranz, B., Dalla Costa, G., Guerrero, A. I., Zabalza, A., Buron, M. D., Comi, G., Leocani, L., Annas, P., Hotopf, M., Penninx, B. W. J. H., Magyari, M., Sørensen, P. S. & 27 others, Montalban, X., Lavelle, G., Ivan, A., Oetzmann, C., White, K. M., Difrancesco, S., Locatelli, P., Mohr, D. C., Aguiló, J., Narayan, V., Folarin, A., Dobson, R. J. B., Dineley, J., Leightley, D., Cummins, N., Vairavan, S., Ranjan, Y., Rashid, Z., Rintala, A., Girolamo, G. D., Preti, A., Simblett, S., Wykes, T., Myin-Germeys, I., Haro, J. M., PAB Members, P. M. & on behalf of the RADAR-CNS consortium, O. B. O. T. R. C., 2022, In: Journal of Clinical Medicine. 11, 23, 7163.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

    Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., De Sèze, J., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun-Frenay, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J., Stankoff, B. & 68 others, Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanché, J. P., Maurousset, A., Ben Nasr, H., Hankiewicz, K., Pottier, C., Maubeuge, N., Dimitri-Boulos, D., Nifle, C., Laplaud, D. A., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand’Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C., Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Shaygannejad, V., Prevost, J., Maimone, D., Skibina, O., Buzzard, K., Van der Walt, A., Karabudak, R., Van Wijmeersch, B., Csepany, T., Spitaleri, D., Vucic, S., Koch-Henriksen, N., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Hilt Christensen, C. C., Rasmussen, P. V., Jensen, Michael Broksgaard, Frederiksen, J. L., Bramow, S., Mathiesen, H. K., Schreiber, K. I., Butzkueven, H., Magyari, M., Kalincik, T. & Leray, E., 2022, In: BMC Medical Research Methodology. 22, 1, 14 p., 155.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

    Yu, H., Graham, G., David, O. J., Kahn, J. M., Savelieva, M., Pigeolet, E., Das Gupta, A., Pingili, R., Willi, R., Ramanathan, K., Kieseier, B. C., Häring, D. A., Bagger, M. & Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 3, p. 283-300 18 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

    Tur, C., Dubessy, A. L., Otero-Romero, S., Amato, M. P., Derfuss, T., Di Pauli, F., Iacobaeus, E., Mycko, M., Abboud, H., Achiron, A., Bellinvia, A., Boyko, A., Casanova, J. L., Clifford, D., Dobson, R., Farez, M. F., Filippi, M., Fitzgerald, K. C., Fonderico, M., Gouider, R. & 29 others, Hacohen, Y., Hellwig, K., Hemmer, B., Kappos, L., Ladeira, F., Lebrun-Frénay, C., Louapre, C., Magyari, M., Mehling, M., Oreja-Guevara, C., Pandit, L., Papeix, C., Piehl, F., Portaccio, E., Ruiz-Camps, I., Selmaj, K., Simpson-Yap, S., Siva, A., Sørensen, Per Soelberg, Sormani, M. P., Trojano, M., Vaknin-Dembinsky, A., Vukusic, S., Weinshenker, B., Wiendl, H., Winkelmann, A., Zuluaga Rodas, M. I., Tintoré, M. & Stankoff, B., 2022, In: Multiple Sclerosis Journal. 28, 9, p. 1424-1456 33 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions

    Sun, S., Folarin, A. A., Zhang, Y., Cummins, N., Liu, S., Stewart, C., Ranjan, Y., Rashid, Z., Conde, P., Laiou, P., Sankesara, H., Dalla Costa, G., Leocani, L., Sørensen, P. S., Magyari, M., Guerrero, A. I., Zabalza, A., Vairavan, S., Bailon, R., Simblett, S. & 8 others, Myin-Germeys, I., Rintala, A., Wykes, T., Narayan, V. A., Hotopf, M., Comi, G., Dobson, R. J. & RADAR-CNS Consortium, R. C., 2022, In: Computer Methods and Programs in Biomedicine. 227, 107204.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. 2021
  23. Published

    Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS

    Sørensen, Per Soelberg, Kopp, T. I., Joensen, H., Olsson, A., Sellebjerg, Finn Thorup & Magyari, M., 2021, In: Multiple Sclerosis and Related Disorders. 50, 102813.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    Lopes, R. D., Higano, C. S., Slovin, S. F., Nelson, A. J., Bigelow, R., Sørensen, Per Soelberg, Melloni, C., Goodman, S. G., Evans, C. P., Nilsson, J., Bhatt, D. L., Clarke, N. W., Olesen, T. K., Doyle-Olsen, B. T., Kristensen, H., Arney, L., Roe, M. T., Alexander, J. H. & PRONOUNCE Study Investigators, P. S. I., 2021, In: Circulation. 144, 16, p. 1295-1307 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial

    Højsgaard Chow, H., Talbot, J., Lundell, H., Gøbel Madsen, C., Marstrand, L., Lange, Theis, Mahler, M. R., Buhelt, S., Hansen, Rikke Holm, Blinkenberg, M., Romme Christensen, J., Sørensen, Per Soelberg, von Essen, Marina Rode, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2021, In: Neurology(R) neuroimmunology & neuroinflammation. 8, 5, p. 1-10

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network

    Iaffaldano, P., Lucisano, G., Butzkueven, H., Hillert, J., Hyde, R., Koch-Henriksen, N., Magyari, M., Pellegrini, F., Spelman, T., Sørensen, Per Soelberg, Vukusic, S. & Trojano, M., 2021, In: Multiple Sclerosis Journal. 27, 10, p. 1543-1555 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Editorial: Challenges in the diagnosis and treatment of multiple sclerosis

    Sørensen, Per Soelberg, 2021, In: Current Opinion in Neurology. 34, 3, p. 275-276 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  28. Published

    Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis

    Oturai, D. B., Bach Søndergaard, H., Koch-Henriksen, N., Andersen, C., Laursen, J. H., Gustavsen, S., Kristensen, J. T., Magyari, M., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup, Thørner, L. W., Ullum, H. & Oturai, A. B., 2021, In: Multiple Sclerosis Journal. 27, 2, p. 188-197 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    Highly effective disease-modifying treatment as initial MS therapy

    Schmierer, K., Sørensen, Per Soelberg & Baker, D., 2021, In: Current Opinion in Neurology. 34, 3, p. 286-294 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    NAverting multiple sclerosis long-term societal and healthcare costs: The Value of Treatment (VoT) project

    Tinelli, M., Pugliatti, M., Antonovici, A., Hausmann, B., Hellwig, K., Quoidbach, V. & Sørensen, Per Soelberg, 2021, In: Multiple Sclerosis and Related Disorders. 54, 103107.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

    Sharmin, S., Lefort, M., Andersen, J. B., Leray, E., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand’Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C. & 31 others, Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Prevost, J., Maimone, D., Skibina, O., Buzzard, K., Van der Walt, A., Van Wijmeersch, B., Csepany, T., Spitaleri, D., Vucic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Jensen, Michael Broksgaard, Fredriksen, Jette Lautrup, Bramow, S., Mathiesen, H. K., Schreiber, K. I., Magyari, M. & Danish Multiple Sclerosis Registry, OFSEP and the MSBase investigators, D. M. S. R. O. A. T. M. I., 2021, In: CNS Drugs. 35, p. 1217–1232

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    Role of B Cells in Multiple Sclerosis and Related Disorders

    Comi, G., Bar-Or, A., Lassmann, H., Uccelli, A., Hartung, H. P., Montalban, X., Sørensen, Per Soelberg, Hohlfeld, R. & Hauser, S. L., 2021, In: Annals of Neurology. 89, 1, p. 13-23 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  33. Published

    Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

    Uccelli, A., Laroni, A., Ali, R., Battaglia, M. A., Blinkenberg, M., Brundin, L., Clanet, M., Fernandez, O., Marriot, J., Muraro, P., Nabavi, S. M., Oliveri, R. S., Radue, E., Ramo Tello, C., Schiavetti, I., Sellner, J., Sørensen, P. S., Sormani, M. P., Wuerfel, J. T., Freedman, M. S. & 1 others, MESEMS investigators, M. I., 2021, In: The Lancet Neurology. 20, 11, p. 917-929 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey

    Gustavsen, S., Olsson, A., Søndergaard, H. B., Andresen, S. R., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A., 2021, In: BMC Neurology. 21, 12 p., 317.

    Research output: Contribution to journal › Journal article › Research › peer-review

  35. Published

    The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

    Andersen, J. B., Sharmin, S., Lefort, M., Koch-Henriksen, N., Sellebjerg, F., Sørensen, P. S., Hilt Christensen, C. C., Rasmussen, P. V., Jensen, M. B., Frederiksen, J. L., Bramow, S., Mathiesen, H. K., Schreiber, K. I., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S., Patti, F. & 66 others, Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C., Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Shaygannejad, V., Prevost, J., Skibina, O., Solaro, C., Karabudak, R., Wijmeersch, B. V., Csepany, T., Spitaleri, D., Vucic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., Sèze, J. D., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J., Stankoff, B., Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanché, J. P., Marousset, A., Patry, I., Hankiewicz, K., Pottier, C., Maubeuge, N., Labeyrie, C., Nifle, C., Leray, E., Laplaud, D. A., Butzkueven, H., Kalincik, T., Vukusic, S. & Magyari, M., 2021, In: Multiple Sclerosis and Related Disorders. 53, 103012.

    Research output: Contribution to journal › Journal article › Research › peer-review

  36. Published

    The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

    Ghezzi, A., Amato, M. P., Edan, G., Hartung, H. P., Havrdová, E. K., Kappos, L., Montalban, X., Pozzilli, C., Sørensen, Per Soelberg, Trojano, M., Vermersch, P. & Comi, G., 2021, In: Multiple Sclerosis Journal. 27, 3, p. 479-482 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis

    Carrión, B., Liu, Yawei, Hadi, M., Lundstrom, J., Christensen, J. R., Ammitzbøll, C., Dziegiel, Morten Hanefeld, Sørensen, Per Soelberg, Comabella, M., Montalban, X., Sellebjerg, Finn Thorup & Issazadeh-Navikas, Shohreh, 2021, In: Neurology: Neuroimmunology & Neuroinflammation. 8, 6, 15 p., e1065.

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. 2020
  39. Published

    Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review

    Alsharoqi, I. A., Aljumah, M., Bohlega, S., Boz, C., Daif, A., El-koussa, S., Inshasi, J., Kurtuncu, M., Müller, T., Retief, C., Sahraian, M. A., Shaygannejad, V., Slassi, I., Taha, K., Zakaria, M. & Sørensen, Per Soelberg, 1 Jun 2020, In: Neurology and Therapy. 9, 1, p. 55-66 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  40. Published

    Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis

    Sellebjerg, Finn Thorup, Blinkenberg, M. & Sørensen, Per Soelberg, 2020, In: CNS Drugs. 34, 3, p. 269-280 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  41. Published

    Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis

    Erdal, J. L., Kopp, T. I., Blinkenberg, M., Petersen, T., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis and Related Disorders. 37, 101431.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis

    Chalmer, T. A., Buron, M., Illes, Z., Papp, V., Theodorsdottir, A., Schäfer, J., Hansen, V., Asgari, N., Skejø, P. B., Jensen, H. B., Sørensen, Per Soelberg & Magyari, M., 2020, In: Journal of neurology, neurosurgery, and psychiatry. 91, 1, p. 67-74

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Comorbidity in Multiple Sclerosis

    Magyari, M. & Sørensen, Per Soelberg, 2020, In: Frontiers in Neurology. 11, 9 p., 851.

    Research output: Contribution to journal › Review › Research › peer-review

  44. Published

    Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β

    Buron, M. D., Magyari, M., Chalmer, T. A., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2020, In: Multiple Sclerosis and Related Disorders. 39, 101894.

    Research output: Contribution to journal › Journal article › Research › peer-review

  45. Published

    Expert opinion on the use of cladribine tablets in clinical practice

    Sørensen, Per Soelberg, Centonze, D., Giovannoni, G., Montalban, X., Selchen, D., Vermersch, P., Wiendl, H., Yamout, B., Salloukh, H. & Rieckmann, P., 2020, In: Therapeutic Advances in Neurological Disorders. 13, 17 p., 1756286420935019.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Barzinji, I., Christensen, J. R., Christensen, M. K., Hansen, V., Illes, Z., Jensen, H. B., Kant, M., Papp, V., Petersen, T., Rasmussen, P. V., Schäfer, J., Theódórsdóttir, Á., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2020, In: Neurology. 95, 8, p. e1041-e1051

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study

    Kopp, T. I., Blinkenberg, M., Petersen, T., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis and Related Disorders. 40, 101956.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    Predictors of treatment outcome in patients with paediatric onset multiple sclerosis

    Kopp, T. I., Blinkenberg, M., Chalmer, T. A., Petersen, T., Ravnborg, M. H., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis Journal. 26, 8, p. 964-975

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. Published

    Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

    Dalla Costa, G., Leocani, L., Montalban, X., Guerrero, A. I., Sørensen, Per Soelberg, Magyari, M., Dobson, R. J. B., Cummins, N., Narayan, V. A., Hotopf, M., Comi, G. & on behalf of the RADAR-CNS consortium, O. B. O. T. R. C., 2020, In: Neurological Sciences. 41, 7, p. 1647-1650 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    The apparently milder course of multiple sclerosis: Changes in the diagnostic criteria, therapy and natural history

    Sørensen, Per Soelberg, Sellebjerg, Finn Thorup, Hartung, H. P., Montalban, X., Comi, G. & Tintoré, M., 2020, In: Brain. 143, 9, p. 2637-2652 16 p.

    Research output: Contribution to journal › Review › Research › peer-review

  51. Published

    The window of opportunity for treatment of progressive multiple sclerosis

    Sørensen, Per Soelberg, Fox, R. J. & Comi, G., 2020, In: Current Opinion in Neurology. 33, 3, p. 262-270

    Research output: Contribution to journal › Journal article › Research › peer-review

  52. Published

    Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19

    Sun, S., Folarin, A. A., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C., Cummins, N., Matcham, F., Dalla Costa, G., Simblett, S., Leocani, L., Lamers, F., Sørensen, P. S., Buron, M., Zabalza, A., Guerrero Pérez, A. I., Penninx, B. W., Siddi, S., Haro, J. M., Myin-Germeys, I. & 7 others, Rintala, A., Wykes, T., Narayan, V. A., Comi, G., Hotopf, M., Dobson, R. J. & RADAR-CNS Consortium, R. C., 2020, In: Journal of Medical Internet Research. 22, 9, 19 p., e19992.

    Research output: Contribution to journal › Journal article › Research › peer-review

  53. 2019
  54. Published

    Worsening of disability caused by relapses in multiple sclerosis: A different approach

    Koch-Henriksen, N., Thygesen, L. C., Sørensen, Per Soelberg & Magyari, M., Jul 2019, In: Multiple Sclerosis and Related Disorders. 32, p. 1-8

    Research output: Contribution to journal › Journal article › Research › peer-review

  55. Published

    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., Dangond, F., Hicking, C. & Vermersch, P., May 2019, In: Multiple Sclerosis Journal. 25, 6, p. 819-827

    Research output: Contribution to journal › Journal article › Research › peer-review

  56. Published

    MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

    Uccelli, A., Laroni, A., Brundin, L., Clanet, M., Fernandez, O., Nabavi, S. M., Muraro, P. A., Oliveri, R. S., Radue, E. W., Sellner, J., Soelberg Sorensen, P., Sormani, M. P., Wuerfel, J. T., Battaglia, M. A., Freedman, M. S., Bonetti, B., Rush, C., Herrera, C., Ramo Tello, C., Miller, D. & 23 others, Szwajcer, D., Strunk, D., Wall, D., Aguera-Morales, E., Rohde, E., Dazzi, F., Comi, G., Martino, G., Izquierdo Ayuso, G., Rabinovitch, H., MacLean, H., Marriott, J., Racosta, J., Arab, L., Gimona, M., Introna, M., Blinkenberg, M., Aghdami, N., Ali, R., Vosoughi, R., Nicholas, R., Marrie, R. A. & Karimi, S., May 2019, In: Trials. 20, 13 p., 263.

    Research output: Contribution to journal › Journal article › Research › peer-review

  57. Published

    The Multiple Sclerosis Care Unit

    Sørensen, Per Soelberg, Giovannoni, G., Montalban, X., Thalheim, C., Zaratin, P. & Comi, G., Apr 2019, In: Multiple Sclerosis Journal. 25, 5, p. 627-636

    Research output: Contribution to journal › Review › Research › peer-review

  58. Published

    Pulsed immune reconstitution therapy in multiple sclerosis

    Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, Mar 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journal › Review › Research › peer-review

  59. Published

    Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy

    Members of Danish Multiple Sclerosis Group, M. O. D. M. S. G., Sellebjerg, Finn Thorup, Magyari, M., Blinkenberg, M., Oturai, A. B., Fredriksen, Jette Lautrup, Jensen, Michael Broksgaard, Tørring, J., Pfleger, C. C. & Weglewski, Arkadiusz, Feb 2019, In: Journal of Neurology. 266, 2, p. 306-315

    Research output: Contribution to journal › Journal article › Research › peer-review

  60. Published

    Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

    On behalf of the ABIRISK Consortium, O. B. O. T. A. C., Jan 2019, In: Journal of Neuroimmunology. 326, p. 19-27

    Research output: Contribution to journal › Journal article › Research › peer-review

  61. Published

    Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Fredriksen, Jette Lautrup, Góra, M. K., Illes, Z., Kant, M., Mezei, Z., Petersen, T., Rasmussen, P. V., Roshanisefat, H., Hassanpour-Kalam-Roudy, H., Sejbæk, T., Tsakiri, A., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2019, In: Neurology. 92, 16, p. e1811-e1820

    Research output: Contribution to journal › Journal article › Research › peer-review

  62. Published

    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Comi, G., Cook, S., Giovannoni, G., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Galazka, A., Nolting, A., Hicking, C. & Dangond, F., 2019, In: Multiple Sclerosis and Related Disorders. 29, p. 168-174 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  63. Published

    Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

    Stuve, O., Sørensen, Per Soelberg, Leist, T., Giovannoni, G., Hyvert, Y., Damian, D., Dangond, F. & Boschert, U., 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journal › Journal article › Research › peer-review

  64. Published

    Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Petersen, E. R., Ammitzbøll, C., Søndergaard, H. B., Oturai, A. B., Sørensen, Per Soelberg, Nilsson, A. C., Börnsen, L., von Essen, Marina Rode & Sellebjerg, Finn Thorup, 2019, In: Journal of Neuroimmunology. 337, 577085.

    Research output: Contribution to journal › Journal article › Research › peer-review

  65. Published

    Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., Vlachos, I. S., McCabe, C., Pers, T. H., Brandes, A., White, C., Keenan, B., Cimpean, M., Winn, P., Panteliadis, I. P., Robbins, A., Andlauer, T. F. M. & 32 others, Zarzycki, O., Dubois, B., Goris, A., Søndergaard, H. B., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Ullum, H., Thørner, L. W., Saarela, J., Cournu-Rebeix, I., Damotte, V., Fontaine, B., Guillot-Noel, L., Lathrop, M., Vukusic, S., Berthele, A., Pongratz, V., Buck, D., Gasperi, C., Graetz, C., Grummel, V., Hemmer, B., Hoshi, M., Knier, B., Korn, T., Lill, C. M., Luessi, F., Karpe, F., Lage, K., Oturai, A., International Multiple Sclerosis Genetics Consortium, I. M. S. G. C. & ANZgene, IIBDGC, WTCCC2, A. I. W., 2019, In: Science. 365, 6460, eaav7188.

    Research output: Contribution to journal › Journal article › Research › peer-review

  66. Published

    Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

    Sellebjerg, Finn Thorup, Royen, L., Sørensen, Per Soelberg, Oturai, A. B. & Jensen, P. E. H., 2019, In: Multiple Sclerosis Journal. 25, 11, p. 1444-1451 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  67. Published

    Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

    Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A. G., Börnsen, L., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Bang Oturai, A., 2019, In: Multiple Sclerosis Journal. 25, 9, p. 1298-1305 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  68. Published

    Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

    International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, I. C. O. S. C. I. A. I. I. M. S. A. N. O. S. D., 2019, In: The Lancet Neurology. 18, 2, p. 185-197 13 p.

    Research output: Contribution to journal › Review › Research › peer-review

  69. Published

    The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis

    Magyari, M. & Sørensen, Per Soelberg, 2019, In: Current Opinion in Neurology. 32, 3, p. 320-326

    Research output: Contribution to journal › Review › Research › peer-review

  70. 2018
  71. Published

    Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M. & 10 others, Sørensen, Per Soelberg, Tintoré, M., Traboulsee, A. L., Trojano, M., Uitdehaag, B. M. J., Vukusic, S., Waubant, E., Weinshenker, B. G., Reingold, S. C. & Cohen, J. A., 2018, In: Lancet Neurology. 17, 2, p. 162-173

    Research output: Contribution to journal › Review › Research › peer-review

  72. Published

    Disability in progressive MS is associated with T2 lesion changes

    Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2018, In: Multiple Sclerosis and Related Disorders. 20, p. 73-77

    Research output: Contribution to journal › Journal article › Research › peer-review

  73. Published

    ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S. & 7 others, Selmaj, K., Siva, A., Sørensen, Per Soelberg, Sormani, M. P., Thalheim, C., Wiendl, H. & Zipp, F., 2018, In: Multiple Sclerosis Journal. 24, 2, p. 96-120

    Research output: Contribution to journal › Journal article › Research › peer-review

  74. Published

    Early versus later treatment start in multiple sclerosis: a register-based cohort study

    the Danish Multiple Sclerosis Group, T. D. M. S. G., 2018, In: European Journal of Neurology. 25, 10, p. 1262-e110

    Research output: Contribution to journal › Journal article › Research › peer-review

  75. Published

    Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

    Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, Per Soelberg, Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 2. E. F. W. G., 2018, In: Multiple Sclerosis Journal. 24, 5, p. 590-603

    Research output: Contribution to journal › Journal article › Research › peer-review

  76. Published

    Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study

    Comi, G., Cook, S., Rammohan, K., Sørensen, Per Soelberg, Vermersch, P., Adeniji, A. K., Dangond, F. & Giovannoni, G., 2018, In: Therapeutic Advances in Neurological Disorders. 11, p. 1-11

    Research output: Contribution to journal › Journal article › Research › peer-review

  77. Published

    Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K., Rieckmann, P., Comi, G., Dangond, F., Adeniji, A. K. & Vermersch, P., 2018, In: Multiple Sclerosis Journal. 24, 12, p. 1594-1604

    Research output: Contribution to journal › Journal article › Research › peer-review

  78. Published

    Smoking affects the interferon beta treatment response in multiple sclerosis

    Petersen, E. R., Oturai, A. B., Koch-Henriksen, N., Magyari, M., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Søndergaard, H. B., 2018, In: Neurology. 90, 7, p. e593-e600

    Research output: Contribution to journal › Journal article › Research › peer-review

  79. Published

    Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

    Bar-Or, A., Grove, R. A., Austin, D. J., Tolson, J. M., VanMeter, S. A., Lewis, E. W., Derosier, F. J., Lopez, M. C., Kavanagh, S. T., Miller, A. E. & Sørensen, Per Soelberg, 2018, In: Neurology. 90, 20, p. e1805-e1814

    Research output: Contribution to journal › Journal article › Research › peer-review

  80. Published

    Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

    Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Giovannoni, G., Hartung, H. P., Havrdova, E., Kappos, L., Pozzilli, C., Sørensen, Per Soelberg, Tackenberg, B., Vermersch, P. & Comi, G., 2018, In: European Journal of Neurology. 25, 5, p. 739-746 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  81. 2017
  82. Published

    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

    Thormann, A., Sørensen, Per Soelberg, Koch-Henriksen, N., Laursen, B. & Magyari, M., 17 Oct 2017, In: Neurology. 89, 16, p. 1668-1675 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  83. Published

    Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis

    Lundell, H., Svolgaard, O., Dogonowski, A., Romme Christensen, J., Selleberg, F., Sørensen, Per Soelberg, Blinkenberg, M., Siebner, Hartwig Roman & Garde, E., Oct 2017, In: Acta Neurologica Scandinavica. 136, 4, p. 330-337 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  84. Published

    Employment, disability pension and income for children with parental multiple sclerosis

    Moberg, J. Y., Laursen, B., Koch-Henriksen, N., Thygesen, L. C., Brødsgaard, A., Sørensen, Per Soelberg & Magyari, M., 28 Sep 2017, In: Multiple Sclerosis. 23, 8, p. 1148-1156 9 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  85. Published

    Safety concerns and risk management of multiple sclerosis therapies

    Sørensen, Per Soelberg, 1 Sep 2017, In: Acta Neurologica Scandinavica. 136, 3, p. 168-186 19 p.

    Research output: Contribution to journal › Review › Research › peer-review

  86. Published

    Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships

    Thormann, A., Sørensen, Per Soelberg, Koch-Henriksen, N., Thygesen, L. C., Laursen, B. & Magyari, M., Jun 2017, In: European Journal of Neurology. 24, 6, p. 825-834 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  87. Published

    A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

    Koch-Henriksen, N., Magyari, M., Sellebjerg, Finn Thorup & Sørensen, Per Soelberg, Feb 2017, In: Multiple Sclerosis. 23, 2, p. 234-241 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  88. Published

    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

    Link, J., Ramanujam, R., Auer, M., Ryner, M., Hässler, S., Bachelet, D., Mbogning, C., Warnke, C., Buck, D., Hyldgaard Jensen, P. E., Sievers, C., Ingenhoven, K., Fissolo, N., Lindberg, R., Grummel, V., Donnellan, N., Comabella, M., Montalban, X., Kieseier, B., Soelberg Sørensen, P. & 12 others, Hartung, H., Derfuss, T., Lawton, A., Sikkema, D., Pallardy, M., Hemmer, B., Deisenhammer, F., Broët, P., Dönnes, P., Davidson, J., Fogdell-Hahn, A. & ABIRISK Consortium, A. C., Feb 2017, In: PLOS ONE. 12, 2, 18 p., e0170395.

    Research output: Contribution to journal › Journal article › Research › peer-review

  89. Published

    Early safety and efficacy of fingolimod treatment in Denmark

    Voldsgaard, A., Koch-Henriksen, N., Magyari, M., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & Oturai, A. B., Jan 2017, In: Acta Neurologica Scandinavica. 135, 1, p. 129-133 5 p.

    Research output: Contribution to journal › Journal article › Research

  90. Published

    Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials

    Sørensen, Per Soelberg, Comi, G., Vollmer, T. L., Montalban, X., Kappos, L., Dadon, Y., Gorfine, T., Margalit, M., Sasson, N., Rubinchick, S. & Knappertz, V., Jan 2017, In: International Journal of M S Care. 19, 1, p. 16-24 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  91. Published

    Defining active progressive multiple sclerosis

    Sellebjerg, Finn Thorup, Börnsen, L., Ammitzbøll, C., Nielsen, Jørgen Erik, Vinther-Jensen, T., Hjermind, L. E., von Essen, M., Ratzer, R. L., Sørensen, Per Soelberg & Romme Christensen, J., 2017, In: Multiple Sclerosis. 23, 13, p. 1727-1735

    Research output: Contribution to journal › Journal article › Research › peer-review

  92. Published

    Evolving concepts in the treatment of relapsing multiple sclerosis

    Comi, G., Radaelli, M. & Sørensen, Per Soelberg, 2017, In: Lancet. 389, 10076, p. 1347-1356

    Research output: Contribution to journal › Review › Research › peer-review

  93. Published

    High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

    Schreiber, K., Magyari, M., Sellebjerg, Finn Thorup, Iversen, P., Garde, E., Madsen, C. G., Börnsen, L., Romme Christensen, J., Ratzer, R., Siebner, Hartwig Roman, Laursen, B. & Sørensen, Per Soelberg, 2017, In: Multiple Sclerosis. 23, 5, p. 675-685

    Research output: Contribution to journal › Journal article › Research › peer-review

  94. Published

    Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents

    Blinkenberg, M. & Sørensen, Per Soelberg, 2017, In: C N S Drugs. 31, 5, p. 357-371

    Research output: Contribution to journal › Review › Research › peer-review

  95. Published

    Survey of diagnostic and treatment practices for multiple sclerosis in Europe

    Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Gionvannoni, G., Hartung, H., Havrdova, E., Kappos, L., Pozzilli, C., Sørensen, Per Soelberg, Tackenberg, B., Vermersch, P. & Comi, G., 2017, In: European Journal of Neurology. 24, 3, p. 516-522

    Research output: Contribution to journal › Journal article › Research › peer-review

  96. 2016
  97. Published

    Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark

    Thormann, A., Magyari, M., Koch-Henriksen, N., Laursen, B. & Sørensen, Per Soelberg, Dec 2016, In: Journal of Neurology. 263, 12, p. 2484-2493 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  98. Published

    Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study

    Moberg, J. Y., Magyari, M., Koch-Henriksen, N., Thygesen, L. C., Laursen, B. & Sørensen, Per Soelberg, Nov 2016, In: Journal of Neurology. 263, 11, p. 2229-2237 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  99. Published

    Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis

    Petersen, E. R., Søndergaard, H. B., Oturai, A. B., Jensen, P. E. H., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Börnsen, L., Nov 2016, In: Multiple Sclerosis and Related Disorders. 10, p. 66-72 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  100. Published

    Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab

    Laursen, J. H., Søndergaard, H. B., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A. B., Nov 2016, In: Multiple Sclerosis and Related Disorders. 10, p. 169-173 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  101. Published

    The Danish multiple sclerosis treatment register

    Magyari, M., Koch-Henriksen, N. & Sørensen, Per Soelberg, 25 Oct 2016, In: Clinical Epidemiology. 8, p. 549-552 4 p.

    Research output: Contribution to journal › Review › Research › peer-review

  102. Published

    Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

    Otero-Romero, S., Sastre-Garriga, J., Comi, G., Hartung, H., Sørensen, Per Soelberg, Thompson, A. J., Vermersch, P., Gold, R. & Montalbán, X., Oct 2016, In: Multiple Sclerosis. 22, 11, p. 1386-1396 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  103. Published

    Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

    George, M. F., Briggs, F. B. S., Shao, X., Gianfrancesco, M. A., Kockum, I., Harbo, H. F., Celius, E. G., Bos, S. D., Hedström, A. K., Shen, L., Bernstein, A., Alfredsson, L., Hillert, J., Olsson, T., Patsopoulos, N. A., De Jager, P. L., Oturai, A. B., Søndergaard, H. B., Sellebjerg, F., Sorensen, P. S. & 14 others, Gomez, R., Caillier, S. J., Cree, B. A. C., Oksenberg, J. R., Hauser, S. L., D'alfonso, S., Leone, M. A., Martinelli-Boneschi, F., Sorosina, M., van der Mei, I., Taylor, B. V., Zhou, S., Schaefer, C. A. & Barcellos, L. F., Aug 2016, In: Neurology: Genetics. 2, 4, 13 p., e87.

    Research output: Contribution to journal › Journal article › Research › peer-review

  104. Published

    Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis

    Dogonowski, A., Blinkenberg, M., Paulson, Olaf B., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Siebner, Hartwig Roman & Madsen, K. H., Aug 2016, In: Journal of Neurology, Neurosurgery and Psychiatry. 87, 8, p. 912-4 3 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  105. Published

    Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

    Macdonell, R., Nagels, G., Laplaud, D., Pozzilli, C., de Jong, B., Martins da Silva, A., Nicholas, R., Lechner-Scott, J. S., Gaebler, J. A., Agarwal, S., Wang, P., Yeh, M., Hovenden, M. & Sørensen, Per Soelberg, Jun 2016, In: Multiple Sclerosis. 22, 7, p. 944-954 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  106. Published

    Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study

    Sørensen, Per Soelberg, Sellebjerg, Finn Thorup, Lycke, J., Färkkilä, M., Créange, A., Lund, C. G., Schluep, M., Fredriksen, Jette Lautrup, Stenager, E., Pfleger, C., Garde, Ellen, Kinnunen, E. & Marhardt, K., May 2016, In: European Journal of Neurology. 23, 5, p. 861-870 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  107. Published

    Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

    Hegen, H., Adrianto, I., Lessard, C. J., Millonig, A., Bertolotto, A., Comabella, M., Giovannoni, G., Guger, M., Hoelzl, M., Khalil, M., Fazekas, F., Killestein, J., Lindberg, R. L. P., Malucchi, S., Mehling, M., Montalbán, X., Rudzki, D., Schautzer, F., Sellebjerg, F., Sorensen, P. S. & 3 others, Deisenhammer, F., Steinman, L. & Axtell, R. C., Apr 2016, In: Neurology: Neuroimmunology & Neuroinflammation. 3, 2, 11 p., e202.

    Research output: Contribution to journal › Journal article › Research › peer-review

  108. Published

    Association between age at onset of multiple sclerosis and vitamin D level-related factors

    Laursen, J. H., Søndergaard, H. B., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A. B., 5 Jan 2016, In: Neurology. 86, 1, p. 88-93 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  109. Published

    Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

    Hermanrud, C., Ryner, M., Luft, T., Jensen, P. E., Ingenhoven, K., Rat, D., Deisenhammer, F., Sørensen, Per Soelberg, Pallardy, M., Sikkema, D., Bertotti, E., Kramer, D., Creeke, P. & Fogdell-Hahn, A., 2016, In: Journal of Immunological Methods. 430, p. 1-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 11025